ATRA Attenuate Proteinuria Via Downregulation of TRPC6 in Glomerulosclerosis Rats Induced by Adriamycin
Overview
Affiliations
Objective: In this research, we explored the molecular mechanism of proteinuria in glomerulosclerosis rats and the protective effects of ATRA.
Methods: This research set up three groups: SHO group, GS group, and ATRA group (15 mg/(kg d), Sigma, St. Louis, MO). The serum creatinine (Scr), urea nitrogen (BUN), and 24-h proteinuria were detected 12 weeks after administration of ATRA. The pathological and ultrastructure changes were observed under light microscope and transmission electron microscope. The protein expression of TGF-β and Col-IV in glomerulus was detected by immunohitochemistry method. The mRNA and the protein expression of glomerular TRPC6 were detected by RT-PCR and Western blot.
Results: In the rat model of GS, the expressions of TRPC6 were significantly elevated compared with the normal rat group; however, the use of ATRA down-regulated the expression of TRPC6 in the glomeruli and attenuated glomerulosclerosis and proteinuria. Scr and BUN were also improved by the treatment of ATRA.
Conclusions: Our results demonstrated that ATRA could ameliorate glomerulosclerosis and proteinuria in GS, which may be related to suppressed expression of TRPC6.
A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis.
Varghese R, Majumdar A Curr Res Physiol. 2022; 5:36-47.
PMID: 35098155 PMC: 8783131. DOI: 10.1016/j.crphys.2021.12.004.
Luo R, Yang K, Wang F, Xu C, Yang T Am J Physiol Renal Physiol. 2020; 319(5):F930-F940.
PMID: 32865014 PMC: 7701266. DOI: 10.1152/ajprenal.00279.2020.
Kuang X, Zhou Q, Li Z, Hu Y, Kang Y, Huang W Int J Genomics. 2019; 2019:2197837.
PMID: 31281825 PMC: 6590578. DOI: 10.1155/2019/2197837.